Tonapofylline

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTonapofylline
Drug Alias Name托那茶碱tonapofyllinetonapofyllinumtonapofilinaAdentri +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsHeart FailureRenal InsufficiencyHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Inc
Active IndicationsN/A
Inactive IndicationsHeart FailureRenal InsufficiencyHepatic Insufficiency

Other Information

ATC CodeN/A
Related LinksKEGG